PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Clinical trial NCT00494897 · COMPLETED

Trial details

NCT number: NCT00494897
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 1996-06-01
Primary completion: 2007-05-01
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.